HCV inhibiting bi-cyclic pyrimidines
US7977342B2 · kind B2 · utility
8Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 9, 2007 |
| Grant date | Jul 12, 2011 |
| Priority date | — |
| Expiry date | Mar 9, 2027 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of bi-cyclic pyrimidines as inhibitors of HCV replication as well as their use in pharmaceutical compositions aimed to treat or combat HCV infections. In addition, the present invention relates to processes for preparation of such pharmaceutical compositions. The present invention also concerns combinations of the present bi-cyclic pyrimidines with other anti-HCV agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.